Cargando…

PRO‐C3 and ADAPT algorithm accurately identify patients with advanced fibrosis due to alcohol‐related liver disease

BACKGROUND: Alcohol is a main cause of preventable deaths and frequently leads to the development of alcohol‐related liver disease. Due to the lack of diagnostics, patients are commonly diagnosed after developing clinical manifestations. Recently, the biomarker PRO‐C3 was shown to accurately identif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madsen, Bjørn S., Thiele, Maja, Detlefsen, Sönke, Kjærgaard, Maria, Møller, Linda S., Trebicka, Jonel, Nielsen, Mette J., Gudmann, Natasja Stæhr, Leeming, Diana J., Karsdal, Morten A., Krag, Aleksander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Identifying Advanced Fibrosis in Alcoholic Liver Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291925/ https://www.ncbi.nlm.nih.gov/pubmed/34251031 http://dx.doi.org/10.1111/apt.16513

Ejemplares similares

Progressive alcohol‐related liver fibrosis is characterised by imbalanced collagen formation and degradation
por: Thiele, Maja, et al.
Publicado: (2021)

Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4
por: Madsen, Bjørn S., et al.
Publicado: (2020)

Mechanisms of fibrosis in acute liver failure
por: He, Yingli, et al.
Publicado: (2015)

Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
por: Lehmann, Jennifer, et al.
Publicado: (2019)

High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal
por: Kjærgaard, Maria, et al.
Publicado: (2017)

Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients
por: Nielsen, Mette Juul, et al.
Publicado: (2019)

Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
por: Israelsen, Mads, et al.
Publicado: (2023)

Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial
por: Madsen, Bjørn Stæhr, et al.
Publicado: (2018)

Hepatorenal Index by B‐Mode Ratio Versus Imaging and Fatty Liver Index to Diagnose Steatosis in Alcohol‐Related and Nonalcoholic Fatty Liver Disease
por: Kjaergaard, Maria, et al.
Publicado: (2022)

Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats
por: Schierwagen, Robert, et al.
Publicado: (2013)

No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial
por: Kimer, Nina, et al.
Publicado: (2018)

How to figure out what CPD/CME you need
por: Mafwiri, Milka, et al.
Publicado: (2017)

Fortification of alcoholic beverages (12% v/v) with tea (Camellia sinensis) reduces harmful effects of alcohol ingestion and metabolism in mouse model
por: Ochanda, S O, et al.
Publicado: (2016)

Quality standards for the management of alcohol-related liver disease: consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology ARLD special interest group
por: Parker, Richard, et al.
Publicado: (2023)

Serum keratin‐18 detects hepatic inflammation and predicts progression in compensated alcohol‐associated liver disease
por: Thorhauge, Katrine Holtz, et al.
Publicado: (2022)

Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease
por: Rasmussen, Ditlev Nytoft, et al.
Publicado: (2021)

Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis
por: Praktiknjo, Michael, et al.
Publicado: (2018)

Alcohol increases circulatory disease mortality in Russia: acute and chronic effects or misattribution of cause?
por: Leon, David A, et al.
Publicado: (2010)

Does legislation to prevent alcohol sales to drunk individuals work? Measuring the propensity for night-time sales to drunks in a UK city
por: Hughes, Karen, et al.
Publicado: (2014)

Measurable effects of local alcohol licensing policies on population health in England
por: de Vocht, F, et al.
Publicado: (2016)

Alcohol-related mortality in deprived UK cities: worrying trends in young women challenge recent national downward trends
por: Shipton, Deborah, et al.
Publicado: (2013)

Do patients who die from an alcohol-related condition ‘drift’ into areas of greater deprivation? Alcohol-related mortality and health selection theory in Scotland
por: Pulford, Andrew, et al.
Publicado: (2018)

Alcohol industry corporate social responsibility initiatives and harmful drinking: a systematic review
por: Mialon, Melissa, et al.
Publicado: (2018)

Failed Attempts to Improve the Reliability of the Alcohol Visual Probe Task Following Empirical Recommendations
por: Jones, Andrew, et al.
Publicado: (2018)

Impact on Product Appeal of Labeling Wine and Beer With (a) Lower Strength Alcohol Verbal Descriptors and (b) Percent Alcohol by Volume (%ABV): An Experimental Study
por: Vasiljevic, Milica, et al.
Publicado: (2018)

Effect of glass markings on drinking rate in social alcohol drinkers
por: Troy, David M., et al.
Publicado: (2017)

Does Alcohol Cue Inhibitory Control Training Survive a Context Shift?
por: Jones, Andrew, et al.
Publicado: (2020)

Smoking, drinking, diet and physical activity—modifiable lifestyle risk factors and their associations with age to first chronic disease
por: Ng, Ryan, et al.
Publicado: (2020)

Declared funding and authorship by alcohol industry actors in the scientific literature: a bibliometric study
por: Golder, Su, et al.
Publicado: (2020)

Are bottle shops using Twitter to increase advertising or encourage drinking during COVID‐19?
por: Winter, Daniel T., et al.
Publicado: (2021)

Alcohol intake and dyslipidemia in male patients with hypertension and diabetes enrolled in a China multicenter registry
por: Ye, Xiao‐Fei, et al.
Publicado: (2023)

A mystery-shopping study to test enforcement of minimum legal purchasing age in Lithuania in 2022
por: Miščikienė, Laura, et al.
Publicado: (2023)

A comparative study of industry responses to government consultations about alcohol and gambling in the UK
por: Bhuptani, Saloni, et al.
Publicado: (2023)

Support for evidence-based alcohol policy in Ireland: results from a representative household survey
por: Calnan, Susan, et al.
Publicado: (2023)

Children with problem-drinking parents in a Swedish national sample: is the risk of harm related to the severity of parental problem drinking?
por: Ramstedt, Mats, et al.
Publicado: (2023)

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
por: McPherson, Stuart, et al.
Publicado: (2017)

Short-term comparative study of high frequency chest wall oscillation and European airway clearance techniques in patients with cystic fibrosis
por: Osman, Leyla P, et al.
Publicado: (2009)

Validation and use of a parametric model for projecting cystic fibrosis survivorship beyond observed data: a birth cohort analysis
por: Jackson, Abaigeal D, et al.
Publicado: (2011)

Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis
por: Wainwright, C E, et al.
Publicado: (2009)

Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
por: Schuster, Antje, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k23a1tltop343q6t16v9h6frfl